Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemia: Efficacy and Safety Results from the AUGMENT-101 Phase 1/2 Study

Abstract | Jun 11, 2023

Author

Aldoss I, et al.

Congress

American Society of Hematology Annual Meeting 2023

San Diego, CA | Dec 9 – 12, 2023